Skip to main content
    V

    VivoSim Labs, Inc. (VIVS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.12
    -0.00 (-2.68%)

    Market Cap: $2.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    VivoSim Labs, Inc. (VIVS) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, VivoSim Labs reported EPS of -$0.03. It beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    83%(19/23)
    Avg Surprise
    +27.58%
    Streak
    6 Q

    Next Report

    VIVS's next report is not on the earnings calendar yet.

    Earnings History

    Of the 23 quarters below that had an estimate, VIVS beat 19, missed 2 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $51000, up 82.1% from $28000 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.03N/AN/AN/AN/AN/AN/AN/ANov 12, 2026$51000
    Jun 30, 2026-$0.25N/AN/AN/AN/AN/AN/AN/AJul 14, 2026$18000
    Mar 31, 2026-$2.21N/AN/AN/AN/A-152.4%N/AN/AMay 29, 2026N/A
    Dec 31, 2025-$1.03N/AN/AN/AN/AN/AN/AN/AFeb 11, 2026$26000
    Sep 30, 2025-$0.98-$2.28N/A+57.02%BeatN/AN/AN/ANov 6, 2025$28000
    Jun 30, 2025-$1.14-$2.28N/A+50.00%BeatN/AN/AN/AAug 12, 2025$37000
    Mar 31, 2025$4.21-$2.28N/A+284.65%BeatN/AN/AN/AMay 30, 2025$51000
    Dec 31, 2024-$2.28-$2.40N/A+5.00%BeatN/AN/AN/AFeb 19, 2025$26000
    Sep 30, 2024-$1.68-$2.64N/A+36.36%BeatN/AN/AN/ANov 8, 2024$30000
    Jun 30, 2024-$2.76-$3.96N/A+30.30%BeatN/AN/AN/AAug 5, 2024$39000
    Mar 31, 2024-$8.04-$5.04N/A-59.52%MissN/AN/AN/AMay 10, 2024$29000
    Dec 31, 2023-$4.80-$4.92N/A+2.44%BeatN/AN/AN/AFeb 8, 2024$5000
    Sep 30, 2023-$5.52-$5.16N/A-6.98%MissN/AN/AN/ANov 9, 2023N/A
    Jun 30, 2023-$5.52-$5.52N/A+0.04%BeatN/AN/AN/AAug 10, 2023$75000
    Mar 31, 2023-$10.27N/AN/AN/AN/AN/AN/AN/AMay 25, 2023$213000
    Dec 31, 2022-$0.37N/AN/AN/AN/AN/AN/AN/AMar 31, 2023$131000
    Sep 30, 2022-$0.38N/AN/AN/AN/AN/AN/AN/ANov 10, 2022$77000
    Jun 30, 2022-$0.37N/AN/AN/AN/AN/AN/AN/AAug 11, 2022N/A
    Mar 31, 2022-$0.22N/AN/AN/AN/AN/AN/AN/AMay 26, 2022$1.50M
    Dec 31, 2021-$0.40N/AN/AN/AN/AN/AN/AN/AMar 31, 2022N/A
    Sep 30, 2021-$0.29N/AN/AN/AN/AN/AN/AN/ANov 4, 2021N/A
    Jun 30, 2021-$0.34N/AN/AN/AN/AN/AN/AN/AAug 5, 2021N/A
    Mar 31, 2021-$0.37N/AN/AN/AN/AN/AN/AN/AMay 20, 2021N/A
    Dec 31, 2020-$1.36N/AN/AN/AN/AN/AN/AN/AMar 31, 2021N/A
    Sep 30, 2020-$1.36-$0.06N/AN/AN/AN/AN/AN/ANov 5, 2020N/A
    Jun 30, 2020-$0.02-$0.06N/A+66.67%BeatN/AN/AN/AAug 6, 2020N/A
    Mar 31, 2020-$0.02-$0.05N/A+60.00%BeatN/AN/AN/AJun 10, 2020N/A
    Dec 31, 2019-$7.20-$0.05N/AN/AN/AN/AN/AN/AFeb 11, 2020$298000
    Sep 30, 2019-$11.42-$12.00N/A+4.83%BeatN/AN/AN/ANov 7, 2019$1.23M
    Jun 30, 2019-$12.00-$12.00N/A0.00%In lineN/AN/AN/AAug 8, 2019$668000
    Mar 31, 2019-$275.41-$0.06N/AN/AN/AN/AN/AN/AMay 22, 2019$680000
    Dec 31, 2018-$14.40-$15.60N/A+7.69%BeatN/AN/AN/AMar 31, 2019$779000
    Sep 30, 2018-$12.00-$16.80N/A+28.57%BeatN/AN/AN/ANov 8, 2018$943000
    Jun 30, 2018-$15.98-$19.20N/A+16.77%BeatN/AN/AN/AAug 9, 2018$689000
    Mar 31, 2018-$0.07-$0.07N/A0.00%In lineN/AN/AN/AMay 31, 2018$1.10M
    Dec 31, 2017-$16.80-$21.60N/A+22.22%BeatN/AN/AN/AMar 31, 2018$1.15M
    Sep 30, 2017-$21.60-$24.00N/A+10.00%BeatN/AN/AN/ANov 9, 2017$1.35M
    Jun 30, 2017-$22.56-$24.00N/A+6.00%BeatN/AN/AN/AAug 9, 2017$990000
    Mar 31, 2017-$0.10-$0.11N/A+6.98%BeatN/AN/AN/AJun 7, 2017$812000
    Dec 31, 2016-$21.60-$22.80N/A+5.26%BeatN/AN/AN/AMar 31, 2017$1.15M
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Mar 31, 2026 was -$5.36, after -$2.51 the year before. It was -$67.30 for the year ended Mar 31, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Mar 31, 2026-$5.36N/A
    Mar 31, 2025-$2.51N/A
    Mar 31, 2024-$23.88N/A
    Mar 31, 2023-$11.39N/A
    Mar 31, 2022-$1.25N/A
    Mar 31, 2021-$3.11N/A
    Mar 31, 2020-$30.64N/A
    Mar 31, 2019-$317.79N/A
    Mar 31, 2018-$61.03N/A
    Mar 31, 2017-$67.30N/A

    Frequently Asked Questions About VIVS

    How often does VIVS beat earnings estimates?

    VivoSim Labs beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate, with an average surprise of +50.78%.